The IPO Buzz: CG Oncology Sets Terms & Launches $200.6 Million IPO
Bladder cancer biotech CG Oncology (CGON Proposed) unveiled the terms and launched its $200.6 million IPO shortly before sunrise on Wall Street today – Thursday, Jan. 18, 2024. CG Oncology is offering 11.8 million shares at $16.00 to $18.00 to raise $200.6 million. The California biotech plans to price its IPO next week – on […]
January 18, 2024 Read More